Ahad Mokhtarzadeh
Overview
Explore the profile of Ahad Mokhtarzadeh including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
203
Citations
3085
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Rasizadeh R, Aghbash P, Mokhtarzadeh A, Poortahmasebi V, Ahangar Oskouee M, Nahand J, et al.
Gene
. 2024 Sep;
932:148904.
PMID: 39218415
Background: Cervical cancer, primarily caused by HPV infection, remains a global health concern. Current treatments face challenges including drug resistance and toxicity. This study investigates combining E5-siRNA with chemotherapy drugs,...
2.
Jahanafrooz Z, Oroojalian F, Mokhtarzadeh A, Rahdar A, Diez-Pascual A
Drug Dev Res
. 2024 Aug;
85(5):e22244.
PMID: 39138855
Nanovaccines have been designed to overcome the limitations associated with conventional vaccines. Effective delivery methods such as engineered carriers or smart nanoparticles (NPs) are critical requisites for inducing self-tolerance and...
3.
Zaer S, Aghamaali M, Amini M, Doustvandi M, Hosseini S, Baradaran B, et al.
Bioimpacts
. 2024 Jun;
14(3):29913.
PMID: 38938754
Introduction: As the most common aggressive primary brain tumor, glioblastoma is inevitably a recurrent malignancy whose patients' prognosis is poor. miR-143 and miR-145, as tumor suppressor miRNAs, are downregulated through...
4.
Taghavi B, Salehi M, Mokhtarzadeh A, Baradaran B
Mol Biotechnol
. 2024 May;
66(9):2673.
PMID: 38795289
No abstract available.
5.
Taghavi B, Salehi M, Mokhtarzadeh A, Baradaran B
Mol Biotechnol
. 2024 Apr;
PMID: 38662256
The B7-H7 is the newest addition to the B7 family of proteins that is present in the majority of malignancies. In this respect, the goal of the work was to...
6.
Mozammel N, Baghbani E, Amini M, Zaer S, Baghay Esfandyari Y, Tohidast M, et al.
Adv Pharm Bull
. 2024 Apr;
14(1):231-240.
PMID: 38585468
Purpose: MicroRNAs (miRNAs) are a group of small regulatory non-coding RNAs, which are dysregulated through tumor progression. let-7 and MIR-145 are both tumor suppressor microRNAs that are downregulated in a...
7.
Bilan F, Amini M, Doustvandi M, Tohidast M, Baghbanzadeh A, Hosseini S, et al.
Bioimpacts
. 2024 Mar;
14(2):27764.
PMID: 38505672
Introduction: Gastric cancer (GC) is the third leading cause of cancer-related death worldwide. microRNAs are a group of regulatory non-coding RNAs that are involved in GC progression. miR-145 as a...
8.
Ahvaz S, Amini M, Yari A, Baradaran B, Jebelli A, Mokhtarzadeh A
Sci Rep
. 2024 Feb;
14(1):3114.
PMID: 38326326
The misregulation of long non-coding RNAs (lncRNAs) is related to the progressive evolution of various human cancers, such as Breast cancer (BC). The role of lncRNA B4GALT1-AS1 has been investigated...
9.
Masoumi J, Ghorbaninezhad F, Saeedi H, Safaei S, Shahgoli V, Ghaffari Jolfayi A, et al.
Biomedicines
. 2023 Dec;
11(12).
PMID: 38137433
Background: Gastric cancer, ranked as the fifth most common cancer worldwide, presents multiple treatment challenges. These obstacles often arise due to cancer stem cells, which are associated with recurrence, metastasis,...
10.
Ghafouri Kalajahi H, Yari A, Amini M, Catal T, Ahmadpour Youshanlui M, Pourbagherian O, et al.
Sci Rep
. 2023 Dec;
13(1):21906.
PMID: 38081950
Gastric cancer (GC) is a leading cause of mortality for many people. Cancer's initiating factors are poorly understood. miR-21 has a crucial function in several malignancies, particularly GC. Furthermore, it...